The problem of broncho-obstructive syndrome early detection in cardiological patients. Review of specialized respiratory questionnaires and their use in patients with comorbid cardiovascular and broncho-obstructive pathologies

The management of patients with cardiovascular pathology and comorbid obstructive pulmonary diseases seems to be an urgent problem against the background of their widespread prevalence among the adult population. According to the latest recommendations of GOLD 2017, it is not possible to diagnose COPD and to select options for pharmacotherapy without assessing the symptoms. Evaluation of symptoms in patients with cardiorespiratory pathology is a key element in the diagnosis of both respiratory and cardiovascular deseases. It is important to conduct differential diagnosis of both nosologies for reliable evaluation of the results of standardized respiratory questionnaires. Many respiratory questionnaires have been developed now; some of them have been validated and recommended for use in clinical practice in patients with COPD and asthma. However, their sensitivity and specificity are different, these questionnaires can`t be used interchangeably. In some cases, a decrease in the informative value of standardized respiratory questionnaires was revealed in patients with comorbid cardiovascular and obstructive pulmonary diseases. There are extremely few scientific works, that assess the same aspects of this problem. In connection with this, the development of specialized questionnaires for patients with comorbid cardiovascular and obstructive pulmonary pathology is relevant.

arterial hypertension, cardiovascular diseases, cardiorespiratory pathology, obstructive pulmonary diseases, COPD, respiratory questionnaires

1. Стародубов В.И., Леонов С.А., Вайсман Д.Ш. Анализ основных тенденций изменения заболеваемости населения хроническими обструктивными болезнями легких и бронхоэктатической болезнью в РФ в 2005-2012 годах. Медицина. 2013; 4.

2. Инициатива Всемирной организации здравоохранения GARD. Российское респираторное общество. URL: http://www.pulmonology.ru/about/gard

3. American Thoracic Society Recommended respiratory disease questionnaires for use with adults and children in epidemiological research (ATS-DLD-78-A). http://www. thoracic.org/statements/resources/archive/rrdquacer. Pdf

4. Global strategy for diagnosis, management and prevention of COPD. Update 2014. http://www.gold.org

5. Voll-Aanerud M, Eagan T.M, Plana E et al. Respiratory symptoms in adults are related to impaired quality of life, regardless of asthma and COPD: results from the European community respiratory health survey. Health Quality Life Outcom 2010; 8: 107.

6. Чучалин А.Г., Халтаев Н.Г., Абросимов В.Н. и др. Оценка распространенности респираторных симптомов и возможности скрининга спирометрии в диагностике хронических легочных заболеваний. Рос. респираторное общество. 2010; 2: 56-66.

7. RESearch on the PrEvalence and the Diagnosis of COPD and Its Tobacco-related Etiology (RESPECT). https://clinicaltrials.gov/ct2/show/NCT02307799

8. Постникова Л.Б., Костров В.А., Болдина М.В., Зеляева Н.В. Распространенность хронической обструктивной болезни легких в крупном промышленном центре (Нижний Новгород). http://www.pulmonology.ru/]

9. Василенко Л.В. Эпидемиология ХОБЛ и эффективность программы легочной реабилитации в промышленном городе Свердловской обл., 2010 г. Автореф. дис.. канд. мед. наук. Самара, 2010.

10. Nacional recommendations OSSN, RKO i REMOT for the diagnosis and treatment of chronic heart failure (IV). Serdechnaya nedostatochnost 2013; 81: 1-94.

11. Pasceri V, Willerson J.T, Yen ET. Direct proinflammatory effect of Creactive protein on human endothelial cells. Circulation 2000; 102 (18): 2165-8.

12. Ратова Л.Г., Зыков К.А., Долгушева Ю.А. и др. Артериальная гипертония и бронхообструктивная патология - особенности клинической картины. Системные гипертензии. 2012; 1: 54-8.

13. Таланцева М.С. Состояние сердечно-сосудистой системы и нейрогуморальной регуляции кровообращения у лиц с артериальной гипертензией в сочетании с обструктивными заболеваниями легких. Автореф. дис.. канд. мед. наук. СПб., 2005.

14. Pasceri V, Willerson J.T, Yen E.T. Direct proinflammatory effect of Creactive protein on human endothelial cells. Circulation 2000; 102 (18): 2165-8.

15. Theander K. Symptoms and impact of symptoms on function and health in patients with COPD and CHF in primary health care. Int J COPD 2014.

16. Чазова И.Е., Чучалин А.Г., Зыков К.А. и др. Диагностика и лечение пациентов с артериальной гипертонией и хронической обструктивной болезнью легких. Рекомендации Российского медицинского общества по артериальной гипертонии и Российского респираторного общества. Системные гипертензии. 2013; 1: 5-34.

17. Anthonisen N.R, Connet J.E, Enright P.L et al. Hospitalizations and Mortality in the Lung health Study. Am J Respir Crit Care Med 2002; 166: 333-9.

18. Theander K, Hasselgren M, Luhr K et al. Symptoms and impact of symptoms on function and health in patients with chronic obstructive pulmonary disease and chronic heart failure in primary health care. Int J Chron Obstruct Pulm Dis 2014; 9: 785-94.

19. Karoli N.A, Tsybulina A.V, Rebrov A.P. Comparative evaluation of subjective sensations of dispnea in patients with various diseases. Klin med 2013; 12: 40-6.

20. Bakke P.S, Rоnmark E, Eagan T. et al. Recommendations for epidemiological studies on COPD. Eur Res J 2011; 38: 1261-77.

21. Котляров С.Н. Структура респираторных симптомов и скрининг спирометрии в оценке хронической обструктивной болезни легких на уровне первичного звена медицинской помощи. Автореф. дис.. канд. мед. наук. Рязань, 2011

22. Jones P.W, Brusselle G. Properties of the COPD assessment test in a cross-sectional European study. Eur Res J 2011; 38 (1): 29-35.

23. Sundh J, Janson C. Clinical COPD Questionnaire score (CCQ) and mortality. Int J Chronic Obstructive Pulm Dis 2012; 7: 833-42.

24. Toren K. Asthma and asthma-like symptoms in adult sassessed by questionnaires. Chest 1993; 104: 600-8.

25. Kotz D, Nelemans P, Van Schayck C.P, Wesseling G. External Validation of a Chronic obstructive pulmonary disease (COPD) diagnostic questionnaire in smokers. Department of General Practice, School for Public Health and Primary Care (CAPHRI), Department of Epidemiology, Maastricht University, Department of Respiratory Medicine, Maastricht University Hospital, NL. http://home.arcor.de/daniel-kotz/2007-30-11_NAF.pdf

26. Martinez F.J, Raczek A.E, Seifer F.D et al. Development and Initial Validation of a Self-Scored COPD Population Screener Questionnaire (COPD-PS). COPD. J Chronic Obstructive Pulm Dis 2008; 5: 85-95.

27. Price D.B, Tinkelman D.G, Halbert R.J et al. ymptom-Based Questionnaire for Identifying COPD in Smokers. Respiration 2006; 73: 285-29.

28. Dalsgaard M, Plesner L.L, Schou M et al. Prevalence of airflow obstruction in patients with stable systolic heart failure. BMC Pulm Med 2017; 17 (1): 6. DOI: 10.1186/s12890-016-0351-9